| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.088 | 0.08 |